Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6
NCT ID: NCT04731896
Last Updated: 2022-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2021-02-08
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A health care provider might recommend labor induction for various reasons: primarily when there's concern for a mother's health or a baby's health.
Combined with oxytocin infusion, amniotomy is commonly used in the induction of labor. However the perfect timing of amniotomy is still unknown.
The aim of this study is to determine whether the early amniotomy followed by oxytocin, or initiating induction of labor with oxytocin followed by late amniotomy, is effective to reach active phase of labor.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Success of Labor Induction Based on a Modified BISHOP Score.
NCT04220320
Premature Rupture of Membranes With a Bishop Score<6: Comparison of Medical Induction/Expectant Management
NCT02825641
Predicting the Outcomes of Labor Induction
NCT03175406
Preterm Induction of Labor Timing of Amniotomy: A Randomized Controlled Trial
NCT03504670
Induction Of Labor: Predictors of Outcomes
NCT04350437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Late Amniotomy
Initiating induction of labor with oxytocin infusion followed by amniotomy 4-6 hours later
No interventions assigned to this group
Early Amniotomy
Early amniotomy initiating induction of labor followed by oxytocin infusion 30 minutes later
Amniotomy
artificial rupture of the amniotic sac
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amniotomy
artificial rupture of the amniotic sac
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full term (36 weeks and 3 days of gestation reached)
* Singletion gestation in cephalic presentation
* Bishop score of ≥ 6
Exclusion Criteria
* Ruptured membranes
* Spontaneous labor
* Multifetal pregnancy
* Dystocic presentation
* Fetal head not fixed at pelvic brim
* Macrosomia
* Hydramnios
* Severe fetal growth restriction
* Major fetal anomaly
* Women with HIV, hepatitis C, hepatitis B
* Women with medical conditions contraindication to a vaginal delivery
* Women with COVID-19 infection
18 Years
48 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Tunis El Manar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Halouani
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital Mongi Slim la Marsa
Tunis, La Marsa, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UTuniselmanar2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.